Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8701 - 8725 of 10912 in total

2,3-Dihydroxy-Valerianic Acid

Experimental
Matched Iupac: … (2R,3R)-2,3-dihydroxy-3-methylpentanoic acid …

5-methyl-6-phenylquinazoline-2,4-diamine

Experimental
Matched Name: … 5-methyl-6-phenylquinazoline-2,4-diamine …
Matched Iupac: … 5-methyl-6-phenylquinazoline-2,4-diamine …

5-Phenylsulfanyl-2,4-Quinazolinediamine

Experimental
Matched Name: … 5-Phenylsulfanyl-2,4-Quinazolinediamine …
Matched Iupac: … 5-(phenylsulfanyl)quinazoline-2,4-diamine …

5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID

Experimental
Matched Name: … 5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID …
Matched Iupac: … 5-[2-(trifluoromethoxy)phenyl]furan-2-carboxylic acid …

Buthionine sulfoximine

Buthionine sulfoximine has been used in trials studying the treatment of Neuroblastoma and Melanoma (Skin).
Investigational
Matched Synonyms: … DL-buthionine-(S,R)-sulfoximine …

Gibberellin A4

Experimental
Matched Iupac: … (1R,2R,5R,8R,9S,10R,11S,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1^{5,8} …

Nalorphine

Nalorphine is a mixed opioid agonist–antagonist. It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics. It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence.
Experimental
Vet approved
Matched Iupac: … (1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca …

2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol

Experimental

Lirentelimab

Lirentelimab is under investigation in clinical trial NCT04856891 (A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis).
Investigational

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

Experimental
Matched Name: … (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol …
Matched Iupac: … (R)-(pyridin-4-yl)({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl})methanol …

L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide

Experimental
Matched Iupac: … (2S)-2-[(2S)-2-aminopropanamido]-N-[(2S,3R)-3-hydroxy-1-phenylbutan-2-yl]propanamide …

(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine

Experimental

Cystic fibrosis transmembrane conductance regulator

Cystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).
Investigational

7-Methyl-7,8-dihydroguanosine 5'-(tetrahydrogen triphosphate)

Experimental
Matched Name: … 7-Methyl-7,8-dihydroguanosine 5'-(tetrahydrogen triphosphate) …
Matched Iupac: … ({[({[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2 …

Tacalcitol

Experimental
Investigational
Matched Iupac: … (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden …

Adafosbuvir

Adafosbuvir is under investigation in clinical trial NCT02894905 (A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335).
Investigational
Matched Iupac: … propan-2-yl (2S)-2-{[(S)-{[(2S,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-fluoro-3,4- …

5-(2-Chlorophenyl)Furan-2-Carboxylic Acid

Experimental
Matched Name: … 5-(2-Chlorophenyl)Furan-2-Carboxylic Acid …
Matched Iupac: … 5-(2-chlorophenyl)furan-2-carboxylic acid …

S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE

Experimental

5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID

Experimental
Matched Name: … 5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID …
Matched Iupac: … 5-[2-(trifluoromethyl)phenyl]furan-2-carboxylic acid …

5-(2-chlorophenyl)furan-2-carbohydrazide

Experimental
Matched Name: … 5-(2-chlorophenyl)furan-2-carbohydrazide …
Matched Iupac: … 5-(2-chlorophenyl)furan-2-carbohydrazide …

Garetosmab

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of episodic, progressive heterotropic ossification. FOP is characterized by episodic inflammatory episodes, which may be precipitated by trauma, including immunizations and minor tissue damage, which usually result in ossification of the lesion. Patients experience abnormal cartilage formation, growth plate dysplasia,...
Investigational

Methylenedioxyethamphetamine

Experimental
Illicit
Matched Iupac: … [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](ethyl)amine …

Tyvelose

Experimental

Capsicum annuum whole

Capsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental

C-CAR039

C-CAR039 is an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR.
Investigational
Displaying drugs 8701 - 8725 of 10912 in total